Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate
Menactra: Meningococcal Polysaccharide Diphtheria Conjugate · 1 trial · 3 indications
Meningococcal serogroups A, C, Y, and W-135 antibody titers were measured by serum bactericidal assay using human complement (SBA-HC)
| Arm | Type | Description |
|---|---|---|
| Menactra® Group 1 | EXPERIMENTAL | Participants aged 2 to \< 4 years |
| Menactra® Group 2 | EXPERIMENTAL | Participants aged 4 to \< 6 years |
| Menactra® Group 3 | ACTIVE_COMPARATOR | Participants aged 6 to \< 11 years |
| Name | Type | Description |
|---|---|---|
| Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate | BIOLOGICAL | 0.5 mL, 2 doses Intramuscular |
Inclusion Criteria : * Aged 2 to \< 11 years on the day of inclusion. * Provision of assent form signed by the subject (depending on age) and informed consent form signed by the parent(s) or another legally acceptable representative. * Subject and parent/legal guardian able to attend all scheduled ...